CVVTF
Covestro AG
OTC Markets OTCPKUSDEQUITY
DELAYED
Last price
65.10
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
65.10
Day high
70.00
Day low
70.00
Volume
851
Market cap
—
P/E (TTM)
—
52W range
65.10 – 70.63
Trailing performance
Returnvs SPY
1W
0.00%
+1.2%
1M
-7.82%
-11.1%
3M
-7.82%
-10.2%
6M
-1.36%
-13.2%
YTD
-1.36%
-13.3%
1Y
-6.95%
-27.1%
3Y
+22.83%
-52.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on CVVTF open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $12.94B | $14.18B | $14.38B | $17.97B | -8.7% |
| Operating revenue | $12.94B | $14.18B | $14.38B | $17.97B | -8.7% |
| Cost of revenue | $11.22B | $12.00B | $12.07B | $15.40B | -6.5% |
| Gross profit | $1.72B | $2.18B | $2.31B | $2.56B | -21.1% |
| Research & development | $342.00M | $392.00M | $374.00M | $361.00M | -12.8% |
| Selling, general & admin | $1.81B | $1.86B | $1.85B | $1.96B | -2.6% |
| Total operating expense | $2.15B | $2.15B | $2.15B | $2.29B | -0.0% |
| Operating income | -$432.00M | $27.00M | $156.00M | $275.00M | -1,700.0% |
| Net interest income | -$131.00M | -$108.00M | -$101.00M | -$113.00M | -21.3% |
| Pre-tax income | -$492.00M | -$27.00M | $73.00M | $130.00M | -1,722.2% |
| Tax provision | $151.00M | $245.00M | $275.00M | $411.00M | -38.4% |
| Net income | -$644.00M | -$266.00M | -$198.00M | -$272.00M | -142.1% |
| Net income to common | -$644.00M | -$266.00M | -$198.00M | -$272.00M | -142.1% |
| Basic EPS | -3.39 | -1.41 | -1.05 | -1.42 | -140.4% |
| Diluted EPS | -3.39 | -1.41 | -1.05 | -1.42 | -140.4% |
| EBIT | -$335.00M | $132.00M | $242.00M | $296.00M | -353.8% |
| EBITDA | $752.00M | $1.12B | $1.14B | $1.65B | -32.6% |
| Basic shares | 189.88M | 188.74M | 189.26M | 190.93M | +0.6% |
| Diluted shares | 189.88M | 188.74M | 189.26M | 190.93M | +0.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $648.00M | $509.00M | $625.00M | $1.20B | +27.3% |
| Cash & short-term investments | $767.00M | $518.00M | $638.00M | $1.20B | +48.1% |
| Accounts receivable | $1.50B | $1.75B | $1.90B | $2.01B | -14.1% |
| Inventory | $2.50B | $2.85B | $2.46B | $2.81B | -12.2% |
| Total current assets | $5.91B | $5.77B | $5.89B | $6.67B | +2.4% |
| Property, plant & equipment | $5.60B | $5.90B | $5.79B | $5.80B | -5.1% |
| Goodwill & intangibles | $1.08B | $1.19B | $1.23B | $1.33B | -8.9% |
| Total assets | $13.47B | $13.63B | $13.64B | $14.59B | -1.2% |
| Total current liabilities | $3.87B | $3.58B | $3.30B | $3.06B | +8.1% |
| Current debt | $1.31B | $519.00M | $541.00M | $154.00M | +153.4% |
| Long-term debt | $1.15B | $1.84B | $2.11B | $2.76B | -37.8% |
| Total debt | $3.13B | $3.10B | $3.39B | $3.66B | +1.2% |
| Total liabilities | $6.45B | $6.95B | $7.02B | $7.46B | -7.2% |
| Retained earnings | $1.68B | $2.17B | $2.29B | $2.48B | -22.7% |
| Shareholder equity | $7.00B | $6.66B | $6.59B | $7.09B | +5.1% |
| Working capital | $2.04B | $2.19B | $2.59B | $3.61B | -6.8% |
| Net tangible assets | $5.91B | $5.47B | $5.36B | $5.75B | +8.2% |
| Shares issued | 207.90M | 189.00M | 189.00M | 193.20M | +10.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$643.00M | -$272.00M | -$202.00M | -$281.00M | — | -136.4% |
| Depreciation & amortisation | $1.09B | $984.00M | $894.00M | $1.35B | — | +10.5% |
| Change in working capital | $27.00M | $83.00M | $333.00M | -$106.00M | — | -67.5% |
| Operating cash flow | $487.00M | $870.00M | $997.00M | $970.00M | — | -44.0% |
| Capital expenditure | -$770.00M | -$781.00M | -$765.00M | -$832.00M | — | +1.4% |
| Investing cash flow | -$1.29B | -$423.00M | -$925.00M | -$477.00M | — | -206.1% |
| Share buybacks | — | $0 | -$49.00M | -$150.00M | $0 | — |
| Dividends paid | -$2.00M | -$1.00M | -$4.00M | -$654.00M | — | -100.0% |
| Financing cash flow | $968.00M | -$565.00M | -$639.00M | $64.00M | — | +271.3% |
| Free cash flow | -$283.00M | $89.00M | $232.00M | $138.00M | — | -418.0% |
| End cash position | $648.00M | $509.00M | $625.00M | $1.20B | — | +27.3% |
| Line item | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.92B | $3.38B | $3.48B | $3.38B | -13.7% |
| Operating revenue | $2.92B | $3.38B | $3.48B | $3.38B | -13.7% |
| Cost of revenue | $2.70B | $2.83B | $3.01B | $3.01B | -4.4% |
| Gross profit | $212.00M | $552.00M | $465.00M | $362.00M | -61.6% |
| Research & development | $87.00M | $84.00M | $90.00M | $118.00M | +3.6% |
| Selling, general & admin | $445.00M | $449.00M | $477.00M | $482.00M | -0.9% |
| Total operating expense | $621.00M | $503.00M | $562.00M | $553.00M | +23.5% |
| Operating income | -$409.00M | $49.00M | -$97.00M | -$191.00M | -934.7% |
| Net interest income | -$27.00M | -$34.00M | -$41.00M | -$25.00M | +20.6% |
| Pre-tax income | -$353.00M | $11.00M | -$141.00M | -$162.00M | -3,309.1% |
| Tax provision | $24.00M | $70.00M | $20.00M | $30.00M | -65.7% |
| Net income | -$378.00M | -$59.00M | -$160.00M | -$192.00M | -540.7% |
| Net income to common | -$378.00M | -$59.00M | -$160.00M | -$192.00M | -540.7% |
| Basic EPS | — | -0.31 | -0.85 | — | — |
| Diluted EPS | — | -0.31 | -0.85 | — | — |
| EBIT | -$298.00M | $45.00M | -$106.00M | -$114.00M | -762.2% |
| EBITDA | $117.00M | $266.00M | $128.00M | $208.00M | -56.0% |
| Basic shares | — | 188.74M | 188.74M | — | — |
| Diluted shares | — | 188.74M | 188.74M | — | — |
| Line item | 2026-06-30 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $474.00M | $648.00M | $489.00M | $742.00M | $509.00M | -26.9% |
| Cash & short-term investments | $984.00M | $767.00M | $566.00M | $789.00M | $518.00M | +28.3% |
| Accounts receivable | $1.93B | $1.50B | $1.87B | $1.97B | $1.75B | +28.4% |
| Inventory | $2.73B | $2.50B | $2.65B | $2.92B | $2.85B | +9.0% |
| Total current assets | $6.18B | $5.91B | $5.64B | $6.28B | $5.77B | +4.6% |
| Property, plant & equipment | $5.64B | $5.60B | $5.62B | $5.79B | $5.90B | +0.7% |
| Goodwill & intangibles | $1.08B | $1.08B | $1.14B | $1.17B | $1.19B | +0.1% |
| Total assets | $13.88B | $13.47B | $13.21B | $14.05B | $13.63B | +3.0% |
| Total current liabilities | $3.66B | $3.87B | $4.04B | $4.76B | $3.58B | -5.3% |
| Current debt | — | $1.31B | — | — | $519.00M | — |
| Long-term debt | — | $1.15B | — | — | $1.84B | — |
| Total debt | — | $3.13B | — | — | $3.10B | — |
| Total liabilities | $6.53B | $6.45B | $7.04B | $7.63B | $6.95B | +1.3% |
| Retained earnings | $348.00M | $1.68B | $2.03B | $2.05B | $2.17B | -79.3% |
| Shareholder equity | $7.32B | $7.00B | $6.15B | $6.41B | $6.66B | +4.6% |
| Working capital | $2.52B | $2.04B | $1.59B | $1.52B | $2.19B | +23.3% |
| Net tangible assets | $6.24B | $5.91B | $5.02B | $5.24B | $5.47B | +5.5% |
| Shares issued | 207.64M | 207.90M | 189.00M | 189.00M | 189.00M | -0.1% |
| Line item | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|
| Net income | -$377.00M | -$59.00M | -$161.00M | -$192.00M | -539.0% |
| Depreciation & amortisation | $415.00M | $221.00M | $234.00M | $322.00M | +87.8% |
| Change in working capital | $288.00M | -$242.00M | -$175.00M | $539.00M | +219.0% |
| Operating cash flow | $301.00M | -$43.00M | -$73.00M | $612.00M | +800.0% |
| Capital expenditure | -$214.00M | -$185.00M | -$180.00M | -$359.00M | -15.7% |
| Investing cash flow | -$825.00M | -$150.00M | -$156.00M | -$111.00M | -450.0% |
| Share buybacks | — | — | — | $0 | — |
| Financing cash flow | $572.00M | -$52.00M | $468.00M | -$542.00M | +1,200.0% |
| Free cash flow | $87.00M | -$228.00M | -$253.00M | $253.00M | +138.2% |
| End cash position | $648.00M | $489.00M | $742.00M | $509.00M | +32.5% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
65.10
+0.00% from price
SMA 20
65.65
-0.84% from price
SMA 50
68.64
-5.15% from price
SMA 100
69.20
-5.92% from price
SMA 200
67.60
-3.70% from price
EMA 12
65.37
-0.42% from price
EMA 26
66.48
-2.07% from price
EMA 50
67.67
-3.79% from price
RSI (14)
0.4
Oversold
MACD (12,26,9)
-1.11
Hist 0.14
ATR (14)
0.00
—
Realised vol 30D
23.2%
Annualised
Bollinger upper
68.97
20, 2σ
Bollinger lower
62.34
20, 2σ
50 / 200 cross
Golden
68.64 vs 67.60
Trend bias
Below 200
-3.70%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.08
Less volatile than market
Correlation to SPY
-0.09
Largely independent
Realised vol 30D
23.2%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-7.8%
Peak to trough
Max drawdown 5Y
-60.6%
Peak to trough
ATR 14
0.00
Average true range
Beta (reported)
—
5Y monthly, from filing
Headlines
Medical Plastics Market to Reach USD 48.77 billion by 2031, Growing at a CAGR of 7.0% — MarketsandMarkets™
GlobeNewswire · 6d ago
Following UPM Biochemicals' Commercial Launch at Europe's Largest Biorefinery in Leuna, New Study Maps Growth Trajectory for Bio-Based Bisphenol Replacements
GlobeNewswire · 11d ago
Covestro (DB:1COV) Returned To Profit, Is The Valuation Upside Already Priced In?
Simply Wall St. · 23d ago
Adnoc Distribution's $1 Billion Shell Deal Targets 6% EPS Lift
GuruFocus.com · 48d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.